BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34946561)

  • 1. NMR Relaxivities of Paramagnetic Lanthanide-Containing Polyoxometalates.
    Venu AC; Nasser Din R; Rudszuck T; Picchetti P; Chakraborty P; Powell AK; Krämer S; Guthausen G; Ibrahim M
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR Relaxivities of Paramagnetic, Ultra-High Spin Heterometallic Clusters within Polyoxometalate Matrix as a Function of Solvent and Metal Ion.
    Schork N; Ibrahim M; Baksi A; Krämer S; Powell AK; Guthausen G
    Chemphyschem; 2022 Oct; 23(19):e202200215. PubMed ID: 35896954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance relaxivities: investigations of ultrahigh-spin lanthanide clusters from 10 MHz to 1.4 GHz.
    Machado JR; Baniodeh A; Powell AK; Luy B; Krämer S; Guthausen G
    Chemphyschem; 2014 Nov; 15(16):3608-13. PubMed ID: 25115895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy.
    Zhou T; Zhang S; Zhang L; Jiang T; Wang H; Huang L; Wu H; Fan Z; Jing S
    Acta Biomater; 2023 Jul; 164():496-510. PubMed ID: 37054962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyoxometalate-based high-spin cluster systems: a NMR relaxivity study up to 1.4 GHz/33 T.
    Ibrahim M; Krämer S; Schork N; Guthausen G
    Dalton Trans; 2019 Nov; 48(41):15597-15604. PubMed ID: 31384871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging.
    Das GK; Johnson NJ; Cramen J; Blasiak B; Latta P; Tomanek B; van Veggel FC
    J Phys Chem Lett; 2012 Feb; 3(4):524-9. PubMed ID: 26286058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic field dependence of solvent proton relaxation by solute dysprosium (III) complexes.
    Kellar KE; Fossheim SL; Koenig SH
    Invest Radiol; 1998 Nov; 33(11):835-40. PubMed ID: 9818318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal and transverse NMR relaxivities of Ln(III)-DOTA complexes: A comprehensive investigation.
    Cicolari D; Santanni F; Grassi L; Brero F; Filibian M; Recca T; Arosio P; Perfetti M; Mariani M; Sessoli R; Lascialfari A
    J Chem Phys; 2021 Dec; 155(21):214201. PubMed ID: 34879662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation and application of ultra-high spin clusters as magnetic resonance relaxation agents.
    Guthausen G; Machado JR; Luy B; Baniodeh A; Powell AK; Krämer S; Ranzinger F; Herrling MP; Lackner S; Horn H
    Dalton Trans; 2015 Mar; 44(11):5032-40. PubMed ID: 25670214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Class of Efficient T
    Yue H; Park JA; Ho SL; Ahmad MY; Cha H; Liu S; Tegafaw T; Marasini S; Ghazanfari A; Kim S; Chae KS; Chang Y; Lee GH
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33076332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
    Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
    Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Strategies in the Design of Responsive Contrast Agents for Magnetic Resonance Imaging: A Case Study with Copper and Zinc.
    Pierre VC; Harris SM; Pailloux SL
    Acc Chem Res; 2018 Feb; 51(2):342-351. PubMed ID: 29356506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation to Biocompatible Dendrimers Increases Lanthanide
    Klemm PJ; Floyd WC; Andolina CM; Fréchet JM; Raymond KN
    Eur J Inorg Chem; 2012 Apr; 2012(12):2108-2114. PubMed ID: 23539072
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.